Janux Therapeutics stock may move 6.3% on earnings release

Janux Therapeutics Inc. shares may experience a 6.3% movement following its earnings release on November 6, according to options data from Bloomberg. Historical analysis of the company's earnings announcements reveals that in several instances, the stock price has deviated from the expected moves suggested by options traders. For instance, in August 2025, options implied a 5.2% move, but the stock actually increased by 5.9%.

Similarly, in May 2025, traders had anticipated a 7.7% move, but the stock only fluctuated by 0.5%. The February 26, 2025 earnings announcement saw an implied move of 3.5%, while the actual price change was 3.0%. In November 2025, options had predicted a substantial 27.3% move, whereas the stock experienced a decline of 4.8%. The August 2025 earnings announcement showed an implied move of 18.4% against a 5.8% decline.

Other notable instances include a 23.0% drop in November 2024 despite an implied move of 19.5%, and an 18.9% expected move in May 2024 with a 1.3% decline. This brief overview is AI-generated and reviewed by an editor.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.